Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Morenzo Abadi Perkasa Tbk. (ENZO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Morenzo Abadi Perkasa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Morenzo Abadi Perkasa Tbk. trades at Rp69 (market cap 147.05B, 8.6M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.1× Morenzo Abadi Perkasa Tbk.'s market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (8.6M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | ENZO | |
|---|---|---|
Market Cap | 310.75B | 147.05B |
Volume | 963.6K | 8.6M |
Lot | 9.64K | 85.96K |
Turnover | 217.67M | 591.25M |
Average Price | 225.89 | 68.78 |
Value | 217.67M | 591.25M |
Indicative Equilibrium Price | 226 | 69 |
Indicative Equilibrium Volume | 1K | 4.14K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Morenzo Abadi Perkasa Tbk.
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →
